Mark Roithmayr
Alzheimer's Drug Discovery Foundation listed Mark Roithmayr as CEO on its 2025 Form 990.
Reported compensation by filing year
Each entry comes from one tax return. Bar lengths compare reported compensation across filings.
Tax year
Reported total$740,169
- From filing organization
- $682,100
- From related organizations
- $0
- Other compensation
- $58,069
Tax year
Reported total$692,422
- From filing organization
- $651,120
- From related organizations
- $0
- Other compensation
- $41,302
Tax year
Reported total$658,993
- From filing organization
- $619,606
- From related organizations
- $0
- Other compensation
- $39,387
Tax year
Reported total$573,133
- From filing organization
- $536,310
- From related organizations
- $0
- Other compensation
- $36,823
Tax year
Reported total$688,104
- From filing organization
- $152,912
- From related organizations
- $356,795
- Other compensation
- $178,397
Tax year
Reported total$644,498
- From filing organization
- $0
- From related organizations
- $477,406
- Other compensation
- $167,092
Tax year
Reported total$625,725
- From filing organization
- $0
- From related organizations
- $463,500
- Other compensation
- $162,225
Tax year
Reported total$641,250
- From filing organization
- $0
- From related organizations
- $475,000
- Other compensation
- $166,250